✨ New Arrivals Just Dropped!Explore
HomeStore

SLU-PP-332 (250mcg) x 60 Tablets

Product image 1
Product image 2
Product image 3

SLU-PP-332 (250mcg) x 60 Tablets

SLU-PP-332 (250mcg) x 60 Tablets

  • SLU-PP-332 (250mcg) is a potent small-molecule REV-ERB agonist that regulates circadian rhythm and enhances mitochondrial activity, making it a powerful compound for metabolic research.
  • This compound has been shown to increase fat oxidation and energy expenditure by activating REV-ERBα/β nuclear receptors, which are central to lipid metabolism and biological clock regulation.
  • SLU-PP-332 supports a shift toward greater energy utilization and metabolic efficiency, making it highly relevant for studies targeting obesity, metabolic syndrome, and weight loss.
  • By modulating the circadian system, SLU-PP-332 may also play a role in optimizing sleep-wake cycles, hormonal balance, and overall energy homeostasis.
  • Ideal for researchers exploring fat loss, endurance, and mitochondrial performance, SLU-PP-332 (250mcg) Tablets x60 provide a targeted approach to investigating advanced metabolic pathways.
$19.50

Original: $65.00

-70%
SLU-PP-332 (250mcg) x 60 Tablets

$65.00

$19.50

Product Information

Shipping & Returns

Description

  • SLU-PP-332 (250mcg) is a potent small-molecule REV-ERB agonist that regulates circadian rhythm and enhances mitochondrial activity, making it a powerful compound for metabolic research.
  • This compound has been shown to increase fat oxidation and energy expenditure by activating REV-ERBα/β nuclear receptors, which are central to lipid metabolism and biological clock regulation.
  • SLU-PP-332 supports a shift toward greater energy utilization and metabolic efficiency, making it highly relevant for studies targeting obesity, metabolic syndrome, and weight loss.
  • By modulating the circadian system, SLU-PP-332 may also play a role in optimizing sleep-wake cycles, hormonal balance, and overall energy homeostasis.
  • Ideal for researchers exploring fat loss, endurance, and mitochondrial performance, SLU-PP-332 (250mcg) Tablets x60 provide a targeted approach to investigating advanced metabolic pathways.